Assertio Holdings | DEPO - Ebitda

Stock Price
18.01
Daily Change
-0.01 -0.06%
Monthly
31.65%
Yearly
101.96%
Q2 Forecast
17.53

Assertio Holdings reported $6.45M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 18.48M 3.11M Dec/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Ironwood Pharmaceuticals USD 81.81M 31.71M Sep/2025
J&J USD 7.19B 2.32B Dec/2025
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Merck USD 8.39B 1.97B Sep/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Omeros USD -47.96M 7.39M Sep/2023
Pfizer USD 6.08B 351M Sep/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025